Effect of atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events
- 1 October 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (7) , 786-789
- https://doi.org/10.1016/s0002-9149(02)02615-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary InterventionCirculation, 2002
- Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarctionThe American Journal of Cardiology, 2002
- Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantationJournal of the American College of Cardiology, 2001
- Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary InterventionCirculation, 2001
- Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein LevelsCirculation, 2001
- Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery diseaseJournal of the American College of Cardiology, 2000
- Effect of statin therapy on restenosis after coronary stent implantationThe American Journal of Cardiology, 2000
- Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantationThe American Journal of Cardiology, 2000
- Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrationsJournal of the American College of Cardiology, 1999
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998